Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025
-
Tutors Warn Time Management and Well-Being Are the Biggest Hurdles Students Face in New School Year
-
2025 CIFTIS: Beijing connects the world with digital intelligence
-
Couture Weaves a Story of Unity as Kruger Products Announces its Designer Roster for the 2025 Cashmere Collection
-
Mobix Labs Technology Cleared for Deployment Into US Navy Communications Systems
-
Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer
-
Forsys Reports Drilling Results from Norasa
-
Erdene Completes Share Consolidation
-
Fury Announces Results of Preliminary Economic Assessment for the Eau Claire Gold Deposit with a Base Case After-Tax NPV (5%) of $554M and After-Tax IRR of 41%
-
Gaming & Leisure Properties Furthers Tribal Partnership With Accretive Long-Term Financing for Caesars Republic Sonoma County
-
Neumora Therapeutics to Participate in Upcoming Conferences in September
-
Playboy to Participate in Lake Street’s Best Ideas Growth Conference
-
Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study
-
Sophos Endpoint Now Integrated with Taegis MDR and XDR, Strengthening Cybersecurity ROI
-
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
-
Saquon Barkley Partners with Wawa in a New Commercial to Celebrate Fans
-
Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treat
-
FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
-
Kamada to Participate in Upcoming September Investor Conferences
-
AlloFlo™ Uveo Achieves Key Milestones Ahead of Launch: 7 Peer-Reviewed Studies & 3,000 U.S. Cases
-
Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
-
Coda Octopus Group Sets Fiscal Third Quarter 2025 Earnings Conference Call for Monday, September 15, 2025, at 10 a.m. Eastern Time
-
AlloFlo™ Uveo Achieves Key Milestones Ahead of Launch: 7 Peer-Reviewed Studies & 3,000 U.S. Cases
-
The Ether Machine Announces Additional 150,000 ETH (currently valued at ~$654M) Invested In-Kind by Blockchains Founder Jeffrey Berns Ahead of Public Market Listing
-
eToro Group to Participate in Upcoming Investor Conferences and Reports Selected July and August Business Metrics
-
Inventus Secures $1.47 Million Gold Pre-Payment from 007 North Bulk Sample at the Pardo Gold Project
-
Biogen and Stoke Therapeutics Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome
-
Baker Hughes Selected by Fervo Energy to Deliver Geothermal Power Generation Equipment for Innovative New Power Plants
-
Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate
-
eMaint Named a Leader in the Verdantix Green Quadrant for CMMS - One of Only Two Vendors Also Recognized for EAM
-
Fusion Fuel’s BrightHy Solutions Wins Tender Processes to Advance to Final Contract Negotiations for Two Green Hydrogen Projects in Southern Europe
-
Safe Harbor Financial Launches Industry’s First Fully Managed Cannabis Banking Program for Financial Institutions
-
CW Petroleum Corp (OTCQB: CWPE) Reports Financial Results for Six Months Ended June 30, 2025
-
Seer Appoints Isaac Ro to its Board of Directors
-
Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer
-
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
-
VitalSource Joins Southern Universities Purchasing Consortium (SUPC) Framework to Further Digital Learning Solutions for UK Institutions
-
Transom Capital-Backed Ampure Acquires Power Designers Sibex
-
PyroGenesis Signs $1.2 Million Energy Transition Contract with Cement Industry Customer
-
CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML
-
Apollo to Proceed with 5-for-1 Share Consolidation
-
Trading by management and close relations of management
-
YieldMax® ETFs Announces Distributions on BIGY, RNTY and SOXY
-
2025 CIFTIS -- What to expect: the health and medical services theme
-
Universal Safety Products, Inc. Declares One-Time Special Cash Dividend of $1.00 per Share of Common Stock
-
2025 CIFTIS: Bank of China highlights upcoming "Mifang Card" and AI financial innovations
-
2025 CIFTIS: Bank of China highlights upcoming "Mifang Card" and AI financial innovations
-
2025 CIFTIS: Beijing to showcase green innovation in environmental services
-
Smart housing for global markets: Technology-driven solutions to launch at 2025 CIFTIS
-
PrimeXBT Launches "Empowering Traders to Succeed" Campaign, Leading a New Era of Trading
